Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
moxifloxacin (avelox) (1 trial)
procaine benzylpenicillin (novocaine) (2 trials)
sulbactam (unasyn) (1 trial)
Lung Diseases (Phase 4)
Lung Diseases, Obstructive (Phase 4)
Pneumonia (Phase 4)
Pulmonary Disease, Chronic Obstructive (Phase 4)
Trials (2 total)
Trial APIs (3 total)